Anna Wu is professor at City of Hope and research professor at UCLA, California. Her research focuses on applications of antibodies for diagnostics and therapy of cancer, utilizing engineered antibodies for targeted radionuclide delivery.
In this episode of Theragnostic Talks she explains what immunoPET and radio immunotherapy are, why antibodies can be used instead of small molecules or peptides and how to use immunoPET for patient selection in immunotherapy. Because, if we see it – we can treat it.
Guest: Anna Wu
By: Gustav Widar and Annette Andrén
Contact us: email@example.com